68Ga-Her2-affibody

N/A

Report date: 2025/09/24 10:03:43
NME

Base Information

Drug Name68Ga-Her2-affibody
Drug Alias Name68Ga-HER2 Affibody68Ga-NOTA-MAL-MZHER2 Affibody68Ga-Her2-affibody
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesThe First Affiliated Hospital Of Beijing University
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Beijing University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A